INVO Bioscience, Inc. (INVO) NASDAQ
0.83
-0.017(-2.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.83
-0.017(-2.00%)
Currency In USD
| Market Cap | 95.07M |
| Enterprise Value | 1.64B |
| P/E Ratio | -0.09 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.33 |
| Price/Book Ratio | 0.4 |
| Enterprise/Revenue | 0.89 |
| Enterprise/EBITDA | -0.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3.95 |
| Operating Margin | -1.39 |
| Return On Assets | -1.46 |
| Return On Equity | -4.47 |
| Revenue | 6.84B |
| Revenue/Share | 4.88 |
| Gross Profit | 2.56B |
| EBITDA | -25.91B |
| Net Income | -25.13B |
| Diluted EPS | -214.64 |
| Total Cash | 2.08B |
| Total Cash/Share | 0.25 |
| Total Debt | 3.62B |
| Total Debt/Equity | 0.72 |
| Current Ratio | 0.12 |
| Book Value Per Share | 4.11 |
| 52-Week Change | -51.57 |
| 52-Week High | 3.5 |
| 52-Week Low | 0.63 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 0.9 |
| Average Volume | 1.15M |
| Shares Outstanding | 3.91M |
| % Held by Institutions | 0.84 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | July 28, 2023 |